Werkgroep Cardiologische centra Nederland

ROCKET-AF (Completed)

Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Medicine
rivaroxaban vs warfarine
Population
Arrhythmia
Phase
III
Starting year
2007

Director of Study

dr. T. Lenderink (Cardioloog)
Sittard-Geleen, Zuyderland Medisch Centrum

ROCKET-AF: News